Related Experiment Video
Updated: Jul 5, 2025

08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.0K
Weekly Paclitaxel for Pregnancy Associated Breast Cancer
Serena Girardelli1, Barbara Bonomo2, Margherita Papale1
1Obstetrics and Gynecology Department, I.R.C.C.S. San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
Clinical Breast Cancer
|January 11, 2024
Summary
Weekly paclitaxel is a safe and effective chemotherapy option for pregnant patients with breast cancer (PrBC). This treatment allows for close monitoring and can be used in both adjuvant and neoadjuvant settings.
Area of Science:
- Oncology
- Maternal-Fetal Medicine
- Pharmacology
Background:
- Pregnancy-associated breast cancer (PrBC) is the most common cancer diagnosed during pregnancy.
- Anthracycline-based chemotherapy is common, but weekly paclitaxel is a viable alternative.

